FLT3 and acute myeloid leukemia: Flow cytometry analysis further demonstrated that quizartinib markedly enhanced the ability of IHCH9033 to induce cell cycle arrest in the G0/G1 phase (Fig. 4b) and to promote caspase-dependent apoptosis in both FLT3-ITD AML cell lines (Fig. 4c, Fig. S2A).